drugset / Trial / NCT05778825

A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors

NCT05778825

Phase 2 Active not recruiting 10 enrolled Memorial Sloan Kettering Cancer Center
RandomizedCrossoverQuadruple-blindTreatment

Summary

This study will test whether minoxidil taken by mouth (oral minoxidil) can improve hair loss caused by cancer treatment in children and young adults. In addition, the researchers will test the safety of oral minoxidil, and see if the study drug causes few or mild side effects in participants. Other purposes of this study include looking at whether participants are able to follow their study drug dosing schedules, and how oral minoxidil affects participants' quality of life.

Timeline

Start
2023-03-10
Primary completion
2027-03
Completion
2027-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Minoxidil Small molecule 0.01 mg/kg Oral
Subject Minoxidil Small molecule 0.02 mg/kg Oral